In Veritas Medical Diagnostics, Inc.
OTC: IVMED0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- G. T. Cooper
- Employees
- 7
- Headquarters
- Inverness, United Kingdom
- IPO year
- 2004
- Market cap
- $120.0
- Website
- https://www.whitebeard.ai
Loading IVMED…
Loading profile data…Frequently asked questions about IVMED
What does In Veritas Medical Diagnostics, Inc. (IVMED) do?
In Veritas Medical Diagnostics, Inc. operates as a development-stage firm, dedicated to researching and developing medical devices designed for near-patient or point-of-care diagnostic applications. The company's flagship product is a prothrombin monitor, crucial for evaluating blood clotting in patients vulnerable to cardiovascular events and c...
Where does IVMED trade?
In Veritas Medical Diagnostics, Inc. (IVMED) trades on the Other OTC.
What sector is IVMED in?
In Veritas Medical Diagnostics, Inc. (IVMED) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of In Veritas Medical Diagnostics, Inc.?
G. T. Cooper is the chief executive officer of In Veritas Medical Diagnostics, Inc. (IVMED).
Where is In Veritas Medical Diagnostics, Inc. headquartered?
In Veritas Medical Diagnostics, Inc. is headquartered in United Kingdom.
Does IVMED pay a dividend?
In Veritas Medical Diagnostics, Inc. (IVMED) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IVMED go public?
In Veritas Medical Diagnostics, Inc. (IVMED) completed its initial public offering in 2004.